PMID- 32817921 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240329 IS - 2452-199X (Electronic) IS - 2452-199X (Linking) VI - 6 IP - 1 DP - 2021 Jan TI - Regulation of the inflammatory cycle by a controllable release hydrogel for eliminating postoperative inflammation after discectomy. PG - 146-157 LID - 10.1016/j.bioactmat.2020.07.008 [doi] AB - Surgery is the final choice for most patients with intervertebral disc degeneration (IDD). Operation-caused trauma will cause inflammation in the intervertebral disc. Serious inflammation will cause tissue defects and induce tissue degeneration, IDD recurrence and the occurrence of other diseases. Therefore, we proposed a scheme to treat recurrence after discectomy by inhibiting inflammation with an aspirin (ASP)-loaded hydrogel to restore the mechanical stability of the spine and relieve local inflammation. ASP-liposomes (ASP-Lips) were incorporated into a photocrosslinkable gelatin-methacryloyl (GelMA) via mixing. This material can effectively alleviate inflammation by inhibiting the release of high mobility group box 1 (HMGB1) from the nucleus to the cytoplasm. We further assessed the expression of inflammatory cytokines, such as interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), and degeneration-related factors, such as type II collagen (COL-2), Aggrecan, matrix metallopeptidases-3 (MMP-3), MMP-13, a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4) and ADAMTS-5 in rat nucleus pulpous cells. The level of IDD was analyzed through H&E, safranin-O staining and immunohistochemistry in rabbit samples. In vitro, we found that ASP-Lip@GelMA treatment significantly decreased inflammatory cytokines, MMP-3 and -13, and ADAMTS-4 and -5 and up-regulated COL-2 and Aggrecan via the inhibited release of HMGB-1 from the nucleus. In vivo, ASP-Lip@GelMA can effectively inhibit inflammation of local tissue after disc surgery and fill local tissue defects. This composite hydrogel system is a promising way to treat the recurrence of IDD after surgery without persistent complications. CI - (c) 2020 [The Author/The Authors]. FAU - Liu, Yu AU - Liu Y AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. FAU - Du, Jiacheng AU - Du J AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. FAU - Peng, Peng AU - Peng P AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. FAU - Cheng, Ruoyu AU - Cheng R AD - Shanghai Institute of Traumatology and Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Shanghai, 200025, PR China. FAU - Lin, Jiayi AU - Lin J AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. FAU - Xu, Congxin AU - Xu C AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. FAU - Yang, Huilin AU - Yang H AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. FAU - Cui, Wenguo AU - Cui W AD - Shanghai Institute of Traumatology and Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Shanghai, 200025, PR China. FAU - Mao, Haiqing AU - Mao H AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. FAU - Li, Yuling AU - Li Y AD - Shanghai Institute of Traumatology and Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Shanghai, 200025, PR China. AD - Department of Orthopaedics, Affiliated Hospital of North Sichuan Medical College, No.63 Wenhua Road, Nanchong, Sichuan, 637000, PR China. FAU - Geng, Dechun AU - Geng D AD - Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. LA - eng PT - Journal Article DEP - 20200812 PL - China TA - Bioact Mater JT - Bioactive materials JID - 101685294 PMC - PMC7426539 OTO - NOTNLM OT - Aspirin OT - Composite hydrogel OT - Inflammation OT - Intervertebral disc degeneration OT - Recurrence COIS- The authors declare no conflict of interest. EDAT- 2020/08/21 06:00 MHDA- 2020/08/21 06:01 PMCR- 2020/08/12 CRDT- 2020/08/21 06:00 PHST- 2020/04/06 00:00 [received] PHST- 2020/07/03 00:00 [revised] PHST- 2020/07/17 00:00 [accepted] PHST- 2020/08/21 06:00 [entrez] PHST- 2020/08/21 06:00 [pubmed] PHST- 2020/08/21 06:01 [medline] PHST- 2020/08/12 00:00 [pmc-release] AID - S2452-199X(20)30134-1 [pii] AID - 10.1016/j.bioactmat.2020.07.008 [doi] PST - epublish SO - Bioact Mater. 2020 Aug 12;6(1):146-157. doi: 10.1016/j.bioactmat.2020.07.008. eCollection 2021 Jan.